Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Excel Venture Management
AddedFeb 13, 2024
UpdatedJun 28, 2026
Excel Venture Management

Excel Venture Management

Operating

Excel Venture Management: A US-based venture capital firm investing in healthcare, IT, and life sciences.

Location
Boston, MA, US
Founded
2008
Firm
Compare
Portfolio
Employees
Website

Investments

InfoBionic
InfoBionic

Total Raised

$151.4M

Rounds

12

Series D$57.8MOctober 2023
Series Unknown$50MSeptember 2018
Series B$8.2MJuly 2016
Orionis Biosciences
Orionis Biosciences

Total Raised

$79.5M

Rounds

8

Private EquityJanuary 2021
Neosensory
Neosensory
Private Equity

Total Raised

$14.2M

Rounds

4

Series A$10MJanuary 2019
Openwater
Openwater

Total Raised

$22M

Rounds

2

Series A$22MDecember 2018
SeedMarch 2018
Cleardata Networks
Cleardata Networks

Total Raised

$132.4M

Rounds

9

Series E$26MNovember 2018
Series D$12MMarch 2017
Series C$25MMay 2015
Series B$7MAugust 2013
Oculus Health
Oculus Health

Total Raised

$20k

Rounds

3

Series AJanuary 2017
Qstream
Qstream

Total Raised

$22.3M

Rounds

6

Series B$15MDecember 2016
Series A$4MJanuary 2015
Welldoc
Welldoc

Total Raised

$55.2M

Rounds

7

Series B$22MDecember 2015
Molecular Templates
Molecular Templates
Public

Total Raised

$348.2M

Rounds

16

Series Unknown$7MJuly 2014
Series C$8.5MOctober 2013
Pathogenetix
Pathogenetix

Total Raised

$28.4M

Rounds

6

Series C$10MOctober 2013
Series B$7.5MNovember 2011
Series B$4MAugust 2011
Lantos Technologies
Lantos Technologies

Total Raised

$31.8M

Rounds

10

Series Unknown$4.1MAugust 2011
Series Unknown$1.6MSeptember 2010
SpringLeaf Therapeutics
SpringLeaf Therapeutics

Total Raised

$34.6M

Rounds

3

Series B$19MJuly 2011
Viridos
Viridos

Total Raised

$202M

Rounds

10

Series Unknown$35MJune 2010
Intrapace
Intrapace

Total Raised

$192.9M

Rounds

7

Series Unknown$49MApril 2010